Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sodium-Glucose Transporter 2 Inhibitors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05914857
What this trial is testing

Evaluation of the Safety and Efficacy of SGLT2 Inhibitors in Pre-diabetic Patients

Who this might be right for
Prediabetic StateImpaired Fasting GlucoseImpaired Glucose Tolerance
Yangjin 120
Post-approval studies (Phase 4)Study completedNCT07120828
What this trial is testing

The Role of CYP8B1 Polymorphisms in Modulating the Biochemical Pathways Affected by SGLT2 Inhibitors in T2DM and Obesity

Who this might be right for
Type 2 DiabetesObese DiabeticsObese Patients (BMI ≥ 30 kg/m²)
Erbil Polytechnic University 260
Not applicableStudy completedNCT06288529
What this trial is testing

EFFECT SGLT2 INHIBITORS ON CONTRAST MEDIUM INDUCED ACUTE KIDNEY INJURY

Who this might be right for
Chronic Kidney DiseasesType2diabetes
University of Health Sciences Balikesir Hospital Eduation and Research 975
Large-scale testing (Phase 3)Study completedNCT06469645
What this trial is testing

The Role of SGLT2i in Management of Moderate AS

Who this might be right for
Moderate Aortic Valve Stenosis
University of East Anglia 104
Early research (Phase 1)Study completedNCT06753994
What this trial is testing

Continuous Ketone Monitoring in People With Type 1 Diabetes Using SGLT2 Inhibitors

Who this might be right for
DiabetesType1diabetesT1D
McGill University 24
Not applicableStudy completedNCT03741972
What this trial is testing

Metabolic and Hemodynamic Effects of the Inhibitors of Type 2 Sodium Glucose Co-transporters (ISGLT2) in Diabetic Patients With Heart Failure

Who this might be right for
Heart Failure
Germans Trias i Pujol Hospital 100
Early research (Phase 1)Study completedNCT03852901
What this trial is testing

Sodium-glucose Co Transporter 2 (sGLT2) Inhibitor and Endogenous Ketone Production

Who this might be right for
EmpaglifozinPhysiological Effects of DrugsHypoglycemic Agents+1 more
National Institute on Aging (NIA) 21
Not applicableStudy completedNCT07022379
What this trial is testing

Sodium-Glucose Cotransporter 2 Inhibitor Use in a National Heart Failure Telemonitoring Program

Who this might be right for
Heart FailureHeart Failure With Preserved Ejection Fraction (HFPEF)Heart Failure With Reduced Ejection Fraction+1 more
Satelia 13,660
Not applicableUnknownNCT06284850
What this trial is testing

Empagliflozin and Red Blood Cell 2,3-biphosphoglycerate Levels

Who this might be right for
Hematocrit ChangeCardiovascular PreventionEmpagliflozin+2 more
Aristotle University Of Thessaloniki 40
Post-approval studies (Phase 4)Study completedNCT04642261
What this trial is testing

Effect of Empagliflozin on Liver Fat in Non-diabetic Patients

Who this might be right for
Non-alcoholic Fatty Liver Disease
The University of Hong Kong 98
Post-approval studies (Phase 4)Looking for participantsNCT06249932
What this trial is testing

Empagliflozin in Heart Failure with Reduced Ejection Fraction and End Stage Renal Disease

Who this might be right for
Heart Failure with Reduced Ejection FractionEnd Stage Renal Disease on Dialysis
National Taiwan University Hospital 95
Not applicableStudy completedNCT05764811
What this trial is testing

SGLT-2 Inhibitor Effects on Cardiac and Hepatic Metabolic Profiles for the Diabetes Patients Combined With Obesity

Who this might be right for
Fatty Liver Disease
National Cheng-Kung University Hospital 40
Large-scale testing (Phase 3)Study completedNCT03979352
What this trial is testing

Effect of SGLT2i in Conjunction With the Artificial Pancreas on Improving the Glycemia in T1DM in the Outpatient Setting

Who this might be right for
Type1 Diabetes Mellitus
Samuel Lunenfeld Research Institute, Mount Sinai Hospital 28
Very early researchUnknownNCT04780438
What this trial is testing

Dapagliflozin to Prevent Atrial Fibrillation Recurrence After Transcatheter Pulmonary Venous Isolation.

Who this might be right for
Atrial Fibrillation RecurrentPulmonary Venous IsolationCatheter Ablation+1 more
G.Gennimatas General Hospital 350
Not applicableStudy completedNCT05990296
What this trial is testing

Evaluating Strategies to Improve Guideline Directed Medical Therapy: The GDMT Research, Education & Assist Trial for Heart Failure Care

Who this might be right for
Heart FailureHeart Failure With Reduced Ejection Fraction
Geisinger Clinic 4,306
Large-scale testing (Phase 3)UnknownNCT06124937
What this trial is testing

Empagliflozin to Prevent Post-Operative Atrial Fibrillation

Who this might be right for
Post-operative Atrial FibrillationCABG
Rajaie Cardiovascular Medical and Research Center 492
Large-scale testing (Phase 3)Study completedNCT01387737
What this trial is testing

Long-Term Safety Study of TA-7284 in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Tanabe Pharma Corporation 1,299
Testing effectiveness (Phase 2)Study completedNCT04818034
What this trial is testing

The Effect of Sodium-glucose Cotransporter (SGLT) 2 Inhibitors on Cystine Stone Formation: A Preliminary Study

Who this might be right for
Cystinuria
University of California, San Francisco 10
Not applicableNot Yet RecruitingNCT07186153
What this trial is testing

Effect of Sodium Glucose Co-transporter 2 Inhibitors on Left Atrial Remodeling in Diabetic Patients

Who this might be right for
SGLT 2 Inhibitors
Assiut University 100
Post-approval studies (Phase 4)Not Yet RecruitingNCT06448130
What this trial is testing

Henagliflozin's Impact on Prediabetes Remission

Who this might be right for
PreDiabetesPrediabetic StateType 2 Diabetes+1 more
Shandong Provincial Hospital 984
Next Page